Quantum-Si’s (QSI) Buy Rating Reiterated at HC Wainwright

HC Wainwright reiterated their buy rating on shares of Quantum-Si (NASDAQ:QSI) in a research report sent to investors on Tuesday morning, Marketbeat Ratings reports. The firm currently has a $4.00 price objective on the stock.

QSI has been the topic of several other reports. Alliance Global Partners reissued a “buy” rating on shares of Quantum-Si in a research report on Friday, August 14th. Weiss Ratings raised shares of Quantum-Si from a “sell (e+)” rating to a “sell (d-)” rating in a research report on Thursday, September 24th. Finally, Wall Street Zen upgraded shares of Quantum-Si from a “sell” rating to a “hold” rating in a research note on Saturday, September 12th. Two investment analysts have rated the stock with a Buy rating, one has given a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat.com, the company has an average rating of “Hold” and a consensus target price of $2.50.

Quantum-Si Stock Up 33.6%

Shares of NASDAQ QSI opened at $1.43 on Tuesday. The firm’s 50-day moving average price is $0.79 and its 200-day moving average price is $0.88. Quantum-Si has a 52-week low of $0.69 and a 52-week high of $3.10. The company has a market cap of $313.00 million, a PE ratio of -3.11 and a beta of 3.21.

Quantum-Si (NASDAQ:QSI) last released its quarterly earnings results on Thursday, August 13th. The company reported ($0.11) earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of ($0.11). Quantum-Si had a negative return on equity of 47.12% and a negative net margin of 6,138.26%.The firm had revenue of $0.34 million for the quarter, compared to the consensus estimate of $0.30 million. As a group, equities research analysts anticipate that Quantum-Si will post -0.47 EPS for the current fiscal year.

Hedge Funds Weigh In On Quantum-Si

Institutional investors and hedge funds have recently bought and sold shares of the stock. IPG Investment Advisors LLC purchased a new stake in Quantum-Si in the second quarter worth about $27,000. WINTON GROUP Ltd bought a new position in shares of Quantum-Si in the second quarter worth about $67,000. Corient Private Wealth LP purchased a new position in shares of Quantum-Si during the 2nd quarter valued at about $34,000. Green Alpha Advisors LLC purchased a new position in shares of Quantum-Si during the 2nd quarter valued at about $41,000. Finally, Renaissance Technologies LLC bought a new position in shares of Quantum-Si during the 1st quarter valued at approximately $91,000. 39.90% of the stock is currently owned by hedge funds and other institutional investors.

Quantum-Si Company Profile

Quantum-Si Incorporated (NASDAQ:QSI) is a life sciences technology company focused on advancing proteomics, the study of proteins and their roles in biological systems. The company develops tools intended to help researchers identify and analyze proteins at the single-molecule level, supporting applications in drug discovery, translational research and precision medicine.

Its primary offering is the Platinum platform, which combines an automated instrument, proprietary sequencing technology, consumables and software for protein analysis.